JP2025503229A5 - - Google Patents
Info
- Publication number
- JP2025503229A5 JP2025503229A5 JP2024544781A JP2024544781A JP2025503229A5 JP 2025503229 A5 JP2025503229 A5 JP 2025503229A5 JP 2024544781 A JP2024544781 A JP 2024544781A JP 2024544781 A JP2024544781 A JP 2024544781A JP 2025503229 A5 JP2025503229 A5 JP 2025503229A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- sequence
- nos
- acid sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2022074078 | 2022-01-26 | ||
| CNPCT/CN2022/074078 | 2022-01-26 | ||
| CN2022110153 | 2022-08-04 | ||
| CNPCT/CN2022/110153 | 2022-08-04 | ||
| CN2022128951 | 2022-11-01 | ||
| CNPCT/CN2022/128951 | 2022-11-01 | ||
| PCT/CN2023/073039 WO2023143343A1 (en) | 2022-01-26 | 2023-01-19 | Anti-her2/trop2 antibodies and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503229A JP2025503229A (ja) | 2025-01-30 |
| JP2025503229A5 true JP2025503229A5 (https=) | 2026-01-29 |
Family
ID=87470782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024544781A Pending JP2025503229A (ja) | 2022-01-26 | 2023-01-19 | 抗ｈｅｒ２／ｔｒｏｐ２抗体及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250059297A1 (https=) |
| EP (1) | EP4469485A4 (https=) |
| JP (1) | JP2025503229A (https=) |
| KR (1) | KR20240135654A (https=) |
| CN (1) | CN118804932A (https=) |
| AU (1) | AU2023210951A1 (https=) |
| CA (1) | CA3246716A1 (https=) |
| MX (1) | MX2024009292A (https=) |
| WO (1) | WO2023143343A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024046455A1 (en) * | 2022-09-01 | 2024-03-07 | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. | Methods for preparing antibody-drug conjugates |
| WO2025038638A1 (en) * | 2023-08-14 | 2025-02-20 | Seagen Inc. | Methods of treating cancer using anti-her2 antibody-drug conjugates |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014371934B2 (en) * | 2013-12-25 | 2020-01-23 | Daiichi Sankyo Company, Limited | Anti-TROP2 antibody-drug conjugate |
| AU2016252771B2 (en) * | 2015-04-22 | 2021-12-16 | Immunomedics, Inc. | Isolation, detection, diagnosis and/or characterization of circulating Trop-2-positive cancer cells |
| TWI727380B (zh) * | 2015-11-30 | 2021-05-11 | 美商輝瑞股份有限公司 | 位點專一性ｈｅｒ２抗體藥物共軛體 |
| EP3504234A4 (en) * | 2016-09-29 | 2020-12-02 | Beijing Hanmi Pharmaceutical Co., Ltd. | CONSTRUCTIONS OF HETERODIMERIC IMMUNOGLOBULINS AND THEIR PREPARATION PROCESSES |
| US20190336615A1 (en) * | 2017-01-27 | 2019-11-07 | Silverback Therapeutics, Inc. | Tumor targeting conjugates and methods of use thereof |
| US20210115152A1 (en) * | 2018-05-16 | 2021-04-22 | Arbele Limited | Composition of bispecific antibodies and method of use thereof |
| EP3906055A4 (en) * | 2019-01-04 | 2023-01-04 | Trio Pharmaceuticals, Inc. | MULTISPECIFIC PROTEIN MOLECULES AND THEIR USES |
| JP2023529846A (ja) * | 2020-06-02 | 2023-07-12 | バイオサイトジェン ファーマシューティカルズ （ベイジン） カンパニー リミテッド | 共通軽鎖免疫グロブリン遺伝子座を有する遺伝子改変非ヒト動物 |
| US20240101717A1 (en) * | 2021-01-22 | 2024-03-28 | Bionecure Therapeutics, Inc. | Anti-her-2/trop-2 constructs and uses thereof |
-
2023
- 2023-01-19 EP EP23746224.7A patent/EP4469485A4/en active Pending
- 2023-01-19 AU AU2023210951A patent/AU2023210951A1/en active Pending
- 2023-01-19 JP JP2024544781A patent/JP2025503229A/ja active Pending
- 2023-01-19 WO PCT/CN2023/073039 patent/WO2023143343A1/en not_active Ceased
- 2023-01-19 MX MX2024009292A patent/MX2024009292A/es unknown
- 2023-01-19 CA CA3246716A patent/CA3246716A1/en active Pending
- 2023-01-19 KR KR1020247027448A patent/KR20240135654A/ko active Pending
- 2023-01-19 US US18/724,021 patent/US20250059297A1/en active Pending
- 2023-01-19 CN CN202380018745.8A patent/CN118804932A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022515318A5 (https=) | ||
| JP2022101693A5 (https=) | ||
| RU2019128134A (ru) | Антитело против gprc5d и молекула, содержащая антитело | |
| JP2020510422A5 (https=) | ||
| JP2021510521A5 (https=) | ||
| JP2023549537A5 (https=) | ||
| FI3582806T3 (fi) | Her2:ta, nkg2d:tä ja cd16:ta sitovia proteiineja | |
| JP2023504016A5 (https=) | ||
| JP2023516004A5 (https=) | ||
| JP2023543493A5 (https=) | ||
| IL276675B2 (en) | Anti-PD-1 antibodies and uses thereof | |
| JP2021522347A5 (https=) | ||
| JP2024538669A5 (https=) | ||
| JP2025507817A5 (https=) | ||
| JP2025503229A5 (https=) | ||
| JP2024515560A5 (https=) | ||
| JP2023037000A5 (https=) | ||
| JP2023549316A5 (https=) | ||
| JP2023545521A5 (https=) | ||
| JP2023516941A5 (https=) | ||
| JP2023509215A5 (https=) | ||
| JP2024020436A5 (https=) | ||
| JP2023514167A5 (https=) | ||
| JP2025513745A5 (https=) | ||
| JP2023517794A5 (https=) |